Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by The University of Texas Health Science Center at San Antonio
Sponsor:
Information provided by (Responsible Party):
Devalingam Mahalingam, The University of Texas Health Science Center at San Antonio
ClinicalTrials.gov Identifier:
NCT01620593
First received: May 31, 2012
Last updated: December 9, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2016
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)